150 related articles for article (PubMed ID: 35675485)
21. High glucose levels accelerate atherosclerosis via NLRP3-IL/ MAPK/NF-κB-related inflammation pathways.
Sun H; Ma X; Ma H; Li S; Xia Y; Yao L; Wang Y; Pang X; Zhong J; Yao G; Liu X; Zhang M
Biochem Biophys Res Commun; 2024 Apr; 704():149702. PubMed ID: 38422898
[TBL] [Abstract][Full Text] [Related]
22. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
[TBL] [Abstract][Full Text] [Related]
23. Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.
Pham PT; Fukuda D; Yagi S; Kusunose K; Yamada H; Soeki T; Shimabukuro M; Sata M
Sci Rep; 2019 Aug; 9(1):11206. PubMed ID: 31371788
[TBL] [Abstract][Full Text] [Related]
24. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
[TBL] [Abstract][Full Text] [Related]
25. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
26. Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice.
Yang X; Lu F; Li L; Li J; Luo J; Zhang S; Liu X; Chen G
BMC Complement Altern Med; 2019 Jan; 19(1):35. PubMed ID: 30704457
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
[TBL] [Abstract][Full Text] [Related]
28. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
29. Chikusetsu saponin IVa ameliorates high fat diet-induced inflammation in adipose tissue of mice through inhibition of NLRP3 inflammasome activation and NF-κB signaling.
Yuan C; Liu C; Wang T; He Y; Zhou Z; Dun Y; Zhao H; Ren D; Wang J; Zhang C; Yuan D
Oncotarget; 2017 May; 8(19):31023-31040. PubMed ID: 28415686
[TBL] [Abstract][Full Text] [Related]
30. Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.
Li X; Zhu Q; Wang Q; Zhang Q; Zheng Y; Wang L; Jin Q
Cardiovasc Drugs Ther; 2020 Oct; 34(5):629-640. PubMed ID: 32444995
[TBL] [Abstract][Full Text] [Related]
31. Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes.
Kim Y; Wang W; Okla M; Kang I; Moreau R; Chung S
J Lipid Res; 2016 Jan; 57(1):66-76. PubMed ID: 26628639
[TBL] [Abstract][Full Text] [Related]
32. DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome.
Birnbaum Y; Tran D; Bajaj M; Ye Y
Basic Res Cardiol; 2019 Aug; 114(5):35. PubMed ID: 31388770
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
[TBL] [Abstract][Full Text] [Related]
37. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals.
Zhang X; Li Y; Yang P; Liu X; Lu L; Chen Y; Zhong X; Li Z; Liu H; Ou C; Yan J; Chen M
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):751-765. PubMed ID: 31941382
[TBL] [Abstract][Full Text] [Related]
38. Guizhi-Shaoyao-Zhimu decoction attenuates monosodium urate crystal-induced inflammation through inactivation of NF-κB and NLRP3 inflammasome.
Zhou GQ; Chen G; Yang J; Qin WY; Ping J
J Ethnopharmacol; 2022 Jan; 283():114707. PubMed ID: 34619319
[TBL] [Abstract][Full Text] [Related]
39. NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction.
Xing JH; Li R; Gao YQ; Wang MY; Liu YZ; Hong J; Dong JZ; Gu HP; Li L
Life Sci; 2019 Dec; 239():116882. PubMed ID: 31705915
[TBL] [Abstract][Full Text] [Related]
40. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
Ye Y; Bajaj M; Yang HC; Perez-Polo JR; Birnbaum Y
Cardiovasc Drugs Ther; 2017 Apr; 31(2):119-132. PubMed ID: 28447181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
